2Mês·

Partial sale of Palantir!

Sold about half of my position with a 265% profit! The stock is currently too overvalued for me, and Palantir had accounted for around 12% of my portfolio due to the profits - too much!!!

I invested the amount directly in $NOVO B (-5,65%) directly! I see more opportunities here this year than with $PLTR

But if there is a significant setback, I will buy in again immediately!

03.01

Palantir Tech

Vendido x25 em € 73,24

€ 1.831,00

267,15%

14 Comentários

Ronald@AlterMann

2Mês

I am up around 320%.
In order not to take away the option to go up, but at the same time to hedge down, I have set an SL

•

Alexander_Bitcoin@Alexander_Bitcoin

2Mês

Palantir continues to rise. But profits are always good 😃

•

Linus@Kapitalismuspur

2Mês

@Alexander_Bitcoin What makes you think that?

••

Alexander_Bitcoin@Alexander_Bitcoin

2Mês

@Kapitalismuspur because there is no such thing as overvalued. As long as the momentum continues, it will continue. The share value also corresponds to what investors attribute to the share. Sometimes regardless of any figures.

••

Linus@Kapitalismuspur

2Mês

@Alexander_Bitcoin The upcoming figures just have to be convincing. Whether this is possible with a P/E ratio of 400 remains questionable for me. I'm still invested, but I'll wait and see :)

••

Sansebastian@Sansebastian

2Mês

Got my insert out and now have 60 left. Can now do what it wants 😄

•

Sebi@Seebi

2Mês

Don't you have any concerns about novo because of the upcoming lawsuits?

••

~ S.@Semos25

2Mês

@Seebi which lawsuit? I only found something from 2024 on the internet

••

0LIV3R@PIXELINVESTOR

2Mês

@Semos25 Novo Nordisk is currently facing several legal challenges, particularly in the USA. A major class action lawsuit has been filed by users of the drugs Ozempic and Wegovy. The plaintiffs report serious side effects such as gastroparesis (stomach paralysis), chronic diarrhea and even tooth loss. They accuse the company of not having provided sufficient information about these risks. The motto is: follow the news closely ^^

•

savvy_investor_420@savvy_investor_420

2Mês

I am clearly up ... approx. 700% and have already thought about an exit, but why shouldn't it continue (I can't think of anything at the moment) and, above all, where to put the money (I can't think of anything at the moment). I'm invested in some major European companies, but I'm rather critical of European equities in 2024... I don't think that will change in 2025. So, keep holding!

••

~ S.@Semos25

2Mês

@PIXELINVESTOR Which company has not been indicted? It doesn't stop any more

••

0LIV3R@PIXELINVESTOR

2Mês

@Semos25 Yes, you're right, Novo has probably also protected itself against such things with its package insert. And even if not, in the end money is paid for a settlement and silence must be maintained about it. 😝

•

~ S.@Semos25

2Mês

@PIXELINVESTOR this is how it looks 👍

••

Gomerdoc@Gomerdoc

2Mês

@PIXELINVESTOR Wegovy: there is a note that it should be used with caution in diabetic gastroparesis because there is limited experience. Diarrhea is also listed as a side effect (very common, >/= one in ten). In Germany. How it is in the USA: no idea. And tooth loss: this is probably due to sugar consumption and poor dental hygiene, which is the reason for using Wegovy in the first place. But: anything is possible in the USA. You certainly have to keep an eye on it, although the fundamental figures for $NOVO B are still great: Must-have products, sales figures actually good, profits actually good, only share price has slumped..... (did I ever mention that "analysts" are a species that normally belong behind bars until they have been clearly proven harmless?😆😉)

•